Have a personal or library account? Click to login
Practical aspects of investigating drug-induced immune hemolytic anemia due to cefotetan or ceftriaxone—a case study approach Cover

Practical aspects of investigating drug-induced immune hemolytic anemia due to cefotetan or ceftriaxone—a case study approach

By: P.A. Arndt  
Paid access
|Oct 2020

Abstract

In the 1970s, the most common causes of drug-induced immune hemolytic anemia were methyldopa and penicillin. Since 1990, the most common causes of drug-induced immune hemolytic anemia have been the second- and third-generation cephalosporins, cefotetan and ceftriaxone. Three case histories illustrate the common findings in the serologic investigation of immune hemolytic anemias due to these two drugs. Immunohematology 2002;18:27–32.

DOI: https://doi.org/10.21307/immunohematology-2019-504 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 27 - 32
Published on: Oct 14, 2020
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2020 P.A. Arndt, published by American National Red Cross
This work is licensed under the Creative Commons License.